Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Edgewise Therapeutics Inc.
EWTX | US
28.66
USD0.84
3.02%
EWTX | US
About Edgewise Therapeutics Inc.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
28.66
Open
27.30
High
29.32
Low
27.03
Edgewise Therapeutics Inc. a biopharmaceutical company discovers develops and commercializes therapies for the treatment of muscle disorders. Its lead product candidate EDG-5506 an orally administered small molecule that is in Phase II clinical trials designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company also develops EDG-7500 a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders. In addition it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The Company was incorporated in 2017 and is headquartered in Boulder Colorado.
View LessEWTX | US
Risk
34.8
Sharpe
-0.04
Luna's Score
54/100
Recommendation
Hold
Luna says (EWTX | US)
What's Working
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Midcap (2B - 10B USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
39.2%1 month
34.8%3 months
93.5%6 months
87.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
6.52
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
-2.60
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-134.29M
MarketCap
2.69B
MarketCap(USD)
2.69B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-28.20
Short ratio
5.47
Short perc.
14.62
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
5.00
Range1M
5.00
Range3M
12.06
Volumes: Market Activity
Rel. volume
1.23
Price X volume
31.28M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.60 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 6.52 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 93.47 | - | Riskier |
| Debt to Equity | 0.01 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 2.69B | - | Emerging |
